Stock Snapshot:

• Ticker: DOC 🏥 

• Price: $18.22

• Change: -0.09 (-0.49%)

• As of: Jul 3, 2025 – 1:10 PM ET 

🧠 The Insider Buzz: Paging Dr. Bullish

Over the past couple of months, Healthpeak insiders have been buying like it’s a clearance sale at the hospital gift shop:

👨⚕️ Tommy G. Thompson (Director): Bought 11,477 shares in May.
👩⚕️ Scott M. Brinker (CEO): Bought 14,087 shares in May and April.
🧑⚕️ Ava Lias-Booker, John T. Thomas, Katherine Sandstrom, Sara Lewis, Pamela Shelley-Kessler – all directors and all buyers.

💰 Total insider purchases since late April exceed $965,000.

🚑 When nearly every member of the board and C-suite buys in, it’s a signal. Not a guarantee, but a strong stethoscope-to-the-ground kind of signal.

💼 Institutional Checkup

Institutions hold 97.91% of float—yep, almost the whole pie.

🏢 Top Holders:

• Vanguard: 111.55M shares

• BlackRock: 81.07M

• State Street, Invesco, Geode, and more: all lining up with big stakes.

📈 Translation: Wall Street is in the waiting room... with snacks.

🔍 For full Institutional Ownership breakdown, see here. 

📊 Financials: Health Check

🧾 Full-Year 2024 Highlights

• Revenue: Up to $2.7 billion

• AFFO/share: $1.60

• Merger: Physicians Realty Trust deal completed

• 8M+ square feet leased across outpatient & lab segments

• $1.3B of asset sales completed at 6.4% cap rate

• Share buybacks: 10.5M shares for $188M

💰 Q1 2025 Results

• Net income/share: $0.06

• AFFO/share: $0.43

• Dividend: $1.22 annualized (Yield: ~6.66%)

• Leasing activity: 1.2M sq ft signed

• Debt: 5.2x Net Debt/EBITDA

🦾 A REIT that leases, grows, buys back shares, AND pays a dividend? That’s almost... athletic.

👉 Want the full picture? Dive into Healthpeak Properties' financials here.

🧮 Valuation Vital Signs

🧪 Lab coats and landlords? The formula almost works—except valuation’s a bit feverish.

🤔 Risks in the Waiting Room

• 📉 Valuation isn’t cheap

• 🧬 Biotech/lab demand soft, outpatient growth still maturing

• 🧱 Post-merger integration takes time, and execution risk remains

• 📉 High interest rates don’t exactly help REITs

💡💡 Curious about another deep oil exploration play?
Check our takes on UnitedHealth Group or even Oscar Health.

📣 Verdict: "Yes, But No. Maybe. Kinda."

✅ Insiders are loading up.
✅ Institutions are holding tight.
✅ Cash flow is solid, and that dividend yield doesn’t lie.

❌ But the stock could be cheaper.
❌ Growth could stall.
❌ There might be better risk/reward elsewhere.

🧬 Diagnosis: Hold If You Have, Buy If You Must, But Don’t Expect Miracles (Or Do!)

Not dead money. But not a slam dunk either. Call it financial physical therapy—slow, steady, not very sexy, but it could pay off.

🚨 Disclaimer:

Investing involves risk. We're funny, not infallible. Proceed with insight—and maybe a second opinion. 

🧭 Want More Like This?

• 🕵️ Insider Purchases Center
• 📣 Follow the Pundits Hub
• 📈 Young Guns & Turnaround Stocks — Track More Growth (and Growing-Pain) Plays
• 😆 Stock Market Humor & Serious-ish Plays
• 🌍 See the world differently and check out more international market picks and fun takes. Explore International Investment Opportunities and value plays 💸 Cheap Stocks with (Maybe) Big Upside
• 🧟 Corporate Resurrection Series — Our special series on companies rising from the financial grave. 🎯 The “Turnaround or Toast” Series (If it still exists. We’re not sure. Ask the intern.)
• 📈 Biotech Bets & Innovation Radar (Problem is we can't detect the Radar)

😂 Laugh, Learn, Invest: funanc1al.com | Funanc1al: Where Even Finance Meets Funny